Skip to content

Clinical trials

Phase 2 Respiratory Tract Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 2 Country / region: Germany Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20102
20161
20171
20181
20211
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Upstream Bio Inc.3
AstraZeneca1
Bayer1
Celgene1
Eli Lilly and Company1
Furiex Pharmaceuticals, Inc1
Pfizer1
Revolution Medicines, Inc.1
Vertex Pharmaceuticals Incorporated1
Windward Bio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases12
Lung Diseases10
Asthma4
Bronchial Diseases4
Fibrosis2
Lung Diseases, Interstitial2
Lung Neoplasms2
Pathologic Processes2
Respiratory Tract Neoplasms2
Acquired Immunodeficiency Syndrome1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.